China Non-Invasive Prenatal Testing (NIPT) Market to Surge to $1,083 Million by 2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 – 2032)” report has been added to ResearchAndMarkets.com’s offering.

This market research report provides key insights into the industry’s rapid growth trajectory through 2032. According to the analysis, the market, which stood at a valuation of US$ 608 million in 2023, is predicted to reach an impressive US$ 1,083 million by the end of 2032.

This significant growth, characterized by a compound annual growth rate of 7.04% from 2024 to 2032, underscores the increasing demand for NIPT solutions in China.

The report offers an exhaustively researched overview of the Chinese non-invasive prenatal testing market with up-to-date data on the current market landscape and a forecast that stretches to 2032. Providing a detailed analysis of market size, volume, and revenue growth, the study serves as a vital tool for stakeholders and industry players looking to make informed decisions.

Equipped with comprehensive historical data from 2018 to 2023, the report not only outlines current market trends but also projects future developments, with a deduced forecast period reflecting the burgeoning potential of NIPT tests in the region. The study meticulously examines the number of tests conducted and the revenues generated, offering a granular insight into the Chinese market dynamics.

Market Opportunities and Drivers

A detailed overview of the critical factors driving the expansion of the China non-invasive prenatal testing market is included in the report. Insights into reimbursement scenarios, a clear depiction of the regulatory framework, and a thorough analysis of market inhibitions and drivers provide readers with a comprehensive understanding of the marketplace.

Strategic Industry Analysis

The study delves deep into recent strategic developments in the industry, such as mergers, acquisitions, partnerships, and collaboration deals. Furthermore, it presents an exploration of the competitive landscape with strategic profiles of leading companies that are shaping the market.

Regulatory and Reimbursement Landscape

The regulatory environment and reimbursement patterns are critical components of the market’s ecosystem. This report provides an insightful review of these factors, conveying essential information pertinent to industry compliance and financial aspects tied to NIPT tests.

This 2024 Report Helps Answer the Following Questions:

• What is the current scenario of the Chinese non-invasive prenatal testing market?
• What is the total market size and forecast (until 2032) for the China non-invasive prenatal testing market?
• How has the potential China market performed so far and how will it perform in the coming years?
• How many NIPT tests were performed in China during 2018 – 2032?
• What are the key marketed NIPT tests available in China?
• What are the major drivers of the Chinese non-invasive prenatal testing market?
• What are the major challenges of the Chinese non-invasive prenatal testing market?
• What is the reimbursement pattern in the Chinese non-invasive prenatal testing market?
• What is the regulatory framework in the Chinese non-invasive prenatal testing market?
• What are the major deals and agreements happening in the non-invasive prenatal testing market?
• Who are the top Chinese market players? What are their happenings, current developments, and scenarios?
• How is the Chinese market predicted to develop in the future?

The Leading Companies in the China Non-Invasive Prenatal Testing Market is Listed Below:

• Basetra
• Berry Genomics
• BGI Diagnosis Co. Ltd

Key Attributes:

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. China Actual Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2032)

5. China Potential Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 – 2032)

6. China Actual Non-Invasive Prenatal Testing Market Size and Forecast (2018 – 2032)

7. China Potential Non-Invasive Prenatal Testing Market Size and Forecast (2018 – 2032)

8. China Non-Invasive Prenatal Testing Market Growth Drivers and Challenges

8.1 Market Growth Drivers

8.2 Market Challenges

9. Non-Invasive Prenatal Testing Comparative Analysis

10. Reimbursement Environment of the China Non-Invasive Prenatal Testing Market

11. Regulation Framework of the China Non-Invasive Prenatal Testing Market

12. Major Deals and Agreements in the Non-Invasive Prenatal Testing Market

12.1 Collaboration Deals

12.2 Venture Capital Investment

12.3 Mergers and Acquisitions

12.4 Exclusive Agreement

12.5 Licensing Agreement

12.6 Distribution Agreement

12.7 Partnership Deals

13. Key Companies Analysis

13.1 Business Overview

13.2 Product Portfolio

13.3 Recent Development

For more information about this report visit https://www.researchandmarkets.com/r/b9w210

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Source link

The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

The post China Non-Invasive Prenatal Testing (NIPT) Market to Surge to $1,083 Million by 2032 – ResearchAndMarkets.com appeared first on Headlines of Today.